MicroRNAs in kidney injury and disease

N Mahtal, O Lenoir, C Tinel, D Anglicheau… - Nature Reviews …, 2022 - nature.com
MicroRNAs (miRNAs) are small non-coding RNAs that regulate gene expression by
degrading or repressing the translation of their target messenger RNAs. As miRNAs are …

Exosomal ncRNAs: Novel therapeutic target and biomarker for diabetic complications

YX Xu, SD Pu, X Li, ZW Yu, YT Zhang, XW Tong… - Pharmacological …, 2022 - Elsevier
Exosomes are discoid vesicles with a diameter of 40–160 nm. They are mainly derived from
the multivesicular body formed by the invagination of lysosomal particles in the cell, which …

Exosomes and their noncoding RNA cargo are emerging as new modulators for diabetes mellitus

W Chang, J Wang - Cells, 2019 - mdpi.com
Diabetes belongs to a group of metabolic disorders characterized by long term high blood
glucose levels due to either inadequate production of insulin (Type 1 diabetes, T1DM) or …

Roles for exosome in various kidney diseases and disorders

V Thongboonkerd - Frontiers in pharmacology, 2020 - frontiersin.org
Exosome is a nanoscale vesicle with a size range of 30–100 nm. It is secreted from cell to
extracellular space by exocytosis after fusion of multivesicular body (MVB)(formed by …

Stem cell-derived and circulating exosomal microRNAs as new potential tools for diabetic nephropathy management

L Peng, Y Chen, S Shi, H Wen - Stem Cell Research & Therapy, 2022 - Springer
Background Despite major advances in the treatment of diabetic nephropathy (DN) in recent
years, it remains the most common cause of end-stage renal disease. An early diagnosis …

Diabetic nephropathy: perspective on extracellular vesicles

Y Lu, D Liu, Q Feng, Z Liu - Frontiers in Immunology, 2020 - frontiersin.org
Diabetic nephropathy (DN) is a major microvascular complication of diabetes mellitus. It is
the most frequent cause of end-stage renal disease with no definitive therapy available so …

Exosomal circ_DLGAP4 promotes diabetic kidney disease progression by sponging miR-143 and targeting ERBB3/NF-κB/MMP-2 axis

S Bai, X Xiong, B Tang, T Ji, X Li, X Qu, W Li - Cell Death & Disease, 2020 - nature.com
Diabetic kidney disease (DKD) is closely associated with the high risk of cardiovascular
disease and mortality. Exosomal circRNAs can exert significant roles in the pathology of …

MicroRNAs in chronic kidney disease: four candidates for clinical application

LJF Peters, J Floege, EAL Biessen… - International journal of …, 2020 - mdpi.com
There are still major challenges regarding the early diagnosis and treatment of chronic
kidney disease (CKD), which is in part due to the fact that its pathophysiology is very …

[HTML][HTML] Urinary exosomes and exosomal CCL2 mRNA as biomarkers of active histologic injury in IgA nephropathy

Y Feng, LL Lv, WJ Wu, ZL Li, J Chen, HF Ni… - The American journal of …, 2018 - Elsevier
IgA nephropathy (IgAN) features variable renal pathology and a heterogeneous clinical
course. Our aim was to search noninvasive biomarkers from urinary exosomes for IgAN …

Autophagy and its therapeutic potential in diabetic nephropathy

YP Han, LJ Liu, JL Yan, MY Chen, XF Meng… - Frontiers in …, 2023 - frontiersin.org
Diabetic nephropathy (DN), the leading cause of end-stage renal disease, is the most
significant microvascular complication of diabetes and poses a severe public health concern …